Lukas D. Sauer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lukas D. Sauer has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Meinhard Kieser
Institute of Medical Biometry University of Heidelberg Heidelberg Germany
6 shared publications - Min Chen
Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany 7
4 shared publications - Silvia Schönenberger
Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany
4 shared publications - Lukas Baumann
Institute of Medical Biometry, Heidelberg University, Heidelberg, Germany
3 shared publications Anja Sander
Institute of Medical Biometry, Heidelberg University , Heidelberg
2 shared publicationsArne Potreck
Department of Neuroradiology, Heidelberg University Hospital , Heidelberg
2 shared publications
Latest Publications
- Open Access
- 5 August 2026
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (8)
Determinants of procedural sedation requirements during endovascular treatment for acute anterior circulation ischaemic stroke: a post-hoc analysis of the INDIVIDUATE trial
Introduction: Procedural sedation during EVT for acute ischaemic stroke is widely used, but factors associated with analgosedative drug requirements remain poorly characterised. We aimed to identify patient and procedural factors associated with analgosedative drug requirements during EVT and explore their association with clinical outcomes. Patients and methods: We performed a post hoc analysis of the randomised INDIVIDUATE trial, including patients with anterior circulation ischaemic stroke undergoing EVT under procedural sedation. Sedation exposure was quantified using mean propofol, remifentanil and esketamine dose rates derived from protocolised 5-min medication records. Multivariable linear regression analyses were used to identify factors associated with sedation requirements. Sensitivity analyses were performed using body weight-normalised dose rates in patients with available body weight data. Exploratory analyses assessed associations between sedation requirements and procedural and clinical outcomes. Results: Of 250 patients enrolled in the INDIVIDUATE trial, 239 were included. In multivariable analyses, male sex was associated with higher propofol and esketamine dose rates; however, after body weight-normalisation, the association with propofol was no longer statistically significant. In weight-normalised sensitivity analyses including 198 patients (82.8%), male sex, ICA + M2 occlusion compared with M1 occlusion and pre-stroke disability remained associated with higher weight-normalised esketamine dose rates (β = 2.39 μg/kg/min, P = .021; β = 13.56 μg/kg/min, P < .001; and β = 2.82 μg/kg/min, P = .028, respectively). Additionally, the number of thrombectomy attempts was associated with higher remifentanil dose rates (β = 0.56 ng/kg/min, P = .010). Higher body weight-normalised esketamine dose rates were associated with less favourable NIHSS change at 24 h (β = 0.17, P = .022). Sedation requirements were not associated with 3-month functional outcome or mortality. Conclusion: Sedation requirements during EVT appeared to vary according to patient- and procedure-related factors, including sex, occlusion pattern, pre-stroke disability and procedural complexity. Sedation intensity was not associated with long-term clinical outcomes, supporting the use of adequate procedural sedation when clinically indicated. Clinical Trial Registration: Clinicaltrials.gov; NCT04578288.
- 5 August 2026
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (8)
Open AccessDeterminants of procedural sedation requirements during endovascular treatment for acute anterior circulation ischaemic stroke: a post-hoc analysis of the INDIVIDUATE trial
Introduction: Procedural sedation during EVT for acute ischaemic stroke is widely used, but factors associated with analgosedative drug requirements remain poorly characterised. We aimed to identify patient and procedural factors associated with analgosedative drug requirements during EVT and explore their association with clinical outcomes. Patients and methods: We performed a post hoc analysis of the randomised INDIVIDUATE trial, including patients with anterior circulation ischaemic stroke undergoing EVT under procedural sedation. Sedation exposure was quantified using mean propofol, remifentanil and esketamine dose rates derived from protocolised 5-min medication records. Multivariable linear regression analyses were used to identify factors associated with sedation requirements. Sensitivity analyses were performed using body weight-normalised dose rates in patients with available body weight data. Exploratory analyses assessed associations between sedation requirements and procedural and clinical outcomes. Results: Of 250 patients enrolled in the INDIVIDUATE trial, 239 were included. In multivariable analyses, male sex was associated with higher propofol and esketamine dose rates; however, after body weight-normalisation, the association with propofol was no longer statistically significant. In weight-normalised sensitivity analyses including 198 patients (82.8%), male sex, ICA + M2 occlusion compared with M1 occlusion and pre-stroke disability remained associated with higher weight-normalised esketamine dose rates (β = 2.39 μg/kg/min, P = .021; β = 13.56 μg/kg/min, P < .001; and β = 2.82 μg/kg/min, P = .028, respectively). Additionally, the number of thrombectomy attempts was associated with higher remifentanil dose rates (β = 0.56 ng/kg/min, P = .010). Higher body weight-normalised esketamine dose rates were associated with less favourable NIHSS change at 24 h (β = 0.17, P = .022). Sedation requirements were not associated with 3-month functional outcome or mortality. Conclusion: Sedation requirements during EVT appeared to vary according to patient- and procedure-related factors, including sex, occlusion pattern, pre-stroke disability and procedural complexity. Sedation intensity was not associated with long-term clinical outcomes, supporting the use of adequate procedural sedation when clinically indicated. Clinical Trial Registration: Clinicaltrials.gov; NCT04578288.
- Open Access
- 4 May 2026
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (5)
Lumbar drainage in intracerebral haemorrhage with intraventricular haemorrhage (DRAIN IVH): protocol for a multi-centre, randomised-controlled, two-arm, assessor-blinded trial
Background: Intracerebral haemorrhage with ventricular extension is associated with poor neurological outcome and high mortality. External ventricular drainage (EVD) is a standard intervention for acute hydrocephalus in such patients, yet the role of an additional early lumbar drainage (LD) remains uncertain. Aim: To evaluate whether early LD leads to improved functional outcomes in patients suffering from ICH with intraventricular haemorrhage (IVH) who require an EVD, compared to patients not receiving early LD. Study design: DRAIN IVH is a multi-centre, parallel-group, open-label randomised controlled trial with blinded endpoint evaluation. Key inclusion criteria are ICH with IVH in the third and/or fourth ventricle with the need for EVD placement due to acute hydrocephalus, age ≥ 18 years and LD insertion within 72 h after symptom onset or last-seen-well. Sample size: A total of 354 patients will be randomised for either early LD plus standard of care (comprising EVD) or standard of care alone. Study endpoints: The primary outcome is the rate of modified Rankin Scale score 0–3 at 180 days. Secondary outcomes include need for VP shunt, need for tracheostomy and EQ-5D. Safety outcomes include mortality, bacterial ventriculitis/meningitis, EVD complications and LD complications. Summary: DRAIN IVH will provide evidence for physicians whether early LD in addition to standard of care treatment leads to better outcomes in ICH with IVH compared to standard of care alone. Trial Registration: Clinicaltrials.gov; NCT06510842.
- 4 May 2026
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (5)
Open AccessLumbar drainage in intracerebral haemorrhage with intraventricular haemorrhage (DRAIN IVH): protocol for a multi-centre, randomised-controlled, two-arm, assessor-blinded trial
Background: Intracerebral haemorrhage with ventricular extension is associated with poor neurological outcome and high mortality. External ventricular drainage (EVD) is a standard intervention for acute hydrocephalus in such patients, yet the role of an additional early lumbar drainage (LD) remains uncertain. Aim: To evaluate whether early LD leads to improved functional outcomes in patients suffering from ICH with intraventricular haemorrhage (IVH) who require an EVD, compared to patients not receiving early LD. Study design: DRAIN IVH is a multi-centre, parallel-group, open-label randomised controlled trial with blinded endpoint evaluation. Key inclusion criteria are ICH with IVH in the third and/or fourth ventricle with the need for EVD placement due to acute hydrocephalus, age ≥ 18 years and LD insertion within 72 h after symptom onset or last-seen-well. Sample size: A total of 354 patients will be randomised for either early LD plus standard of care (comprising EVD) or standard of care alone. Study endpoints: The primary outcome is the rate of modified Rankin Scale score 0–3 at 180 days. Secondary outcomes include need for VP shunt, need for tracheostomy and EQ-5D. Safety outcomes include mortality, bacterial ventriculitis/meningitis, EVD complications and LD complications. Summary: DRAIN IVH will provide evidence for physicians whether early LD in addition to standard of care treatment leads to better outcomes in ICH with IVH compared to standard of care alone. Trial Registration: Clinicaltrials.gov; NCT06510842.
- 2 April 2026
- Published by The R Foundation
baskoptr: Utility-Based Optimization for Basket Trial Designs
A unified framework for optimizing basket trial designs. To this end, the package supplies several utility functions and also a function for executing optimization algorithms on basket trial designs. The considered utility functions are discussed in Sauer et al. (2025) .
- 2 April 2026
- Published by The R Foundation
baskoptr: Utility-Based Optimization for Basket Trial Designs
A unified framework for optimizing basket trial designs. To this end, the package supplies several utility functions and also a function for executing optimization algorithms on basket trial designs. The considered utility functions are discussed in Sauer et al. (2025) .
- 19 March 2026
- Published by The R Foundation
baskwrap: Wrapper Package for Several Basket Trial R Packages
A simple interface to switch between two methods for calculating basket trial characteristics, numerical integration ("exact") and Monte Carlo simulation ("simulated") for the basket trial design by Fujikawa et al. 2020 . The exact implementation is from the 'baskexact' package, see Baumann (2024) . The simulated implementation is from the 'basksim' package, which was developed for Baumann et al. (2024) . The package's syntax is compatible with the 'basksim' syntax and easily extendable.
- 19 March 2026
- Published by The R Foundation
baskwrap: Wrapper Package for Several Basket Trial R Packages
A simple interface to switch between two methods for calculating basket trial characteristics, numerical integration ("exact") and Monte Carlo simulation ("simulated") for the basket trial design by Fujikawa et al. 2020 . The exact implementation is from the 'baskexact' package, see Baumann (2024) . The simulated implementation is from the 'basksim' package, which was developed for Baumann et al. (2024) . The package's syntax is compatible with the 'basksim' syntax and easily extendable.
- Open Access
- 28 May 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (5) , e0323097
Utility-based optimization of Fujikawa’s basket trial design – Pre-specified protocol of a comparison study
Basket trial designs are a type of master protocol in which the same therapy is tested in several strata of the patient cohort. Many basket trial designs implement borrowing mechanisms. These allow sharing information between similar strata with the goal of increasing power in responsive strata while at the same time constraining type-I error inflation to a bearable threshold. These borrowing mechanisms can be tuned using numerical tuning parameters. The optimal choice of these tuning parameters is subject to research. In a comparison study using simulations and numerical calculations, we are planning to investigate the use of utility functions for quantifying the compromise between power and type-I error inflation and the use of numerical optimization algorithms for optimizing these functions. The present document is the protocol of this comparison study, defining each step of the study in accordance with the ADEMP scheme for pre-specification of simulation studies.
- 28 May 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (5) , e0323097
Open AccessUtility-based optimization of Fujikawa’s basket trial design – Pre-specified protocol of a comparison study
Basket trial designs are a type of master protocol in which the same therapy is tested in several strata of the patient cohort. Many basket trial designs implement borrowing mechanisms. These allow sharing information between similar strata with the goal of increasing power in responsive strata while at the same time constraining type-I error inflation to a bearable threshold. These borrowing mechanisms can be tuned using numerical tuning parameters. The optimal choice of these tuning parameters is subject to research. In a comparison study using simulations and numerical calculations, we are planning to investigate the use of utility functions for quantifying the compromise between power and type-I error inflation and the use of numerical optimization algorithms for optimizing these functions. The present document is the protocol of this comparison study, defining each step of the study in accordance with the ADEMP scheme for pre-specification of simulation studies.
- Open Access
- 28 March 2025
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 282 (6) , 939-945
Laparoscopic Resection Rectopexy Versus Delorme’s Procedure In Full-thickness Rectal Prolapse
Objective: The DELORES trial investigated whether laparoscopic resection rectopexy (LRR) is superior to Delorme’s procedure (DP) in full-thickness rectal prolapse. Background: Multiple perineal and transabdominal procedures are current practice for rectal prolapse surgery. Evidence from adequately designed randomized studies addressing the question of which of these procedures are superior in terms of recurrence and bowel function is lacking. Methods: DELORES was a randomized, observer-blinded, expertise-based multicenter trial. Patients with full-thickness rectal prolapse were eligible. The primary outcome was time to recurrence of full-thickness rectal prolapse within 24 months after primary surgery. The main secondary endpoints were morbidity, hospital stay, quality of life, constipation, and fecal incontinence (DRKS00000482). Results: A total of 358 patients were screened between September 2010 and January 2016. Based on screening, 70 patients were randomized and 65 were included in the analysis (33 LRR and 32 DP procedures). The median follow-up was 23.9 months. Analysis of the primary outcome showed that LRR was superior to DP ( P =0.0012). During the 24-month follow-up, 8.2% of patients in the LRR group had a full-thickness prolapse recurrence versus 42.8% in the DP group. The median time to recurrence was 17.8 months for LRR and 8.2 months for DP. The median duration of surgery was 212 min (LRR) versus 77 min (DP). Overall postoperative morbidity was low. The reoperation rate was higher for DP (0% LRR vs. 33.3% DP). Quality of life (FIQL) and incontinence scores (Wexner) were more favorable for LRR at 24-month follow-up. Conclusions: LRR is superior to DP in terms of recurrence and has favorable functional results.
- 28 March 2025
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 282 (6) , 939-945
Open AccessLaparoscopic Resection Rectopexy Versus Delorme’s Procedure In Full-thickness Rectal Prolapse
Objective: The DELORES trial investigated whether laparoscopic resection rectopexy (LRR) is superior to Delorme’s procedure (DP) in full-thickness rectal prolapse. Background: Multiple perineal and transabdominal procedures are current practice for rectal prolapse surgery. Evidence from adequately designed randomized studies addressing the question of which of these procedures are superior in terms of recurrence and bowel function is lacking. Methods: DELORES was a randomized, observer-blinded, expertise-based multicenter trial. Patients with full-thickness rectal prolapse were eligible. The primary outcome was time to recurrence of full-thickness rectal prolapse within 24 months after primary surgery. The main secondary endpoints were morbidity, hospital stay, quality of life, constipation, and fecal incontinence (DRKS00000482). Results: A total of 358 patients were screened between September 2010 and January 2016. Based on screening, 70 patients were randomized and 65 were included in the analysis (33 LRR and 32 DP procedures). The median follow-up was 23.9 months. Analysis of the primary outcome showed that LRR was superior to DP ( P =0.0012). During the 24-month follow-up, 8.2% of patients in the LRR group had a full-thickness prolapse recurrence versus 42.8% in the DP group. The median time to recurrence was 17.8 months for LRR and 8.2 months for DP. The median duration of surgery was 212 min (LRR) versus 77 min (DP). Overall postoperative morbidity was low. The reoperation rate was higher for DP (0% LRR vs. 33.3% DP). Quality of life (FIQL) and incontinence scores (Wexner) were more favorable for LRR at 24-month follow-up. Conclusions: LRR is superior to DP in terms of recurrence and has favorable functional results.
- Open Access
- 1 January 2025
- Published by SAGE Publications in Therapeutic Advances in Neurological Disorders
- Vol. 18
Association of hemodynamic variability during endovascular stroke treatment with functional outcome and parenchymal hemorrhage
Background: Higher blood pressure variability (BPV) in patients suffering from acute ischemic stroke were shown to be associated with worse functional outcome and hemorrhagic transformation. Objectives: To assess the influence of blood pressure variability during endovascular stroke treatment on functional outcome and parenchymal hemorrhage. Design: We performed a post-hoc exploratory analysis of the individualized blood pressure management during endovascular thrombectomy under procedural sedation in acute ischemic stroke (INDIVIDUATE) study, which was a randomized clinical trial investigating an individualized blood pressure management strategy in comparison to a standardized treatment strategy during endovascular stroke treatment. Methods: Several BPV parameters, such as procedure time of systolic blood pressure (SBP) in a range of a preprocedural baseline SBP ± 10 mmHg and ±20 mmHg, maximal and minimal SBP, variance and average real variability of intraprocedural SBP values were tested for association with functional outcome and PH1/PH2 hemorrhages in the current post-hoc analysis. Results: Regression analyses were performed in 250 patients and revealed an association of variance of intraprocedural SBP (aOR, 1.002 (95% CI, 1.0004–1.004); p = 0.016) and average real variability of SBP (aOR, 1.105 (95% CI, 1.019–1.199); p = 0.016) with favorable outcome (modified Rankin Scale 0–2). Conclusion: In our study, intraprocedural BPV parameters during endovascular stroke treatment were positively associated with favorable clinical outcomes. Potential underlying mechanisms should be further explored to better understand the effects of hemodynamics during the hyperacute time frame of endovascular stroke therapy. Trial registration: Clinicaltrials.gov; NCT04578288.
- 1 January 2025
- Published by SAGE Publications in Therapeutic Advances in Neurological Disorders
- Vol. 18
Open AccessAssociation of hemodynamic variability during endovascular stroke treatment with functional outcome and parenchymal hemorrhage
Background: Higher blood pressure variability (BPV) in patients suffering from acute ischemic stroke were shown to be associated with worse functional outcome and hemorrhagic transformation. Objectives: To assess the influence of blood pressure variability during endovascular stroke treatment on functional outcome and parenchymal hemorrhage. Design: We performed a post-hoc exploratory analysis of the individualized blood pressure management during endovascular thrombectomy under procedural sedation in acute ischemic stroke (INDIVIDUATE) study, which was a randomized clinical trial investigating an individualized blood pressure management strategy in comparison to a standardized treatment strategy during endovascular stroke treatment. Methods: Several BPV parameters, such as procedure time of systolic blood pressure (SBP) in a range of a preprocedural baseline SBP ± 10 mmHg and ±20 mmHg, maximal and minimal SBP, variance and average real variability of intraprocedural SBP values were tested for association with functional outcome and PH1/PH2 hemorrhages in the current post-hoc analysis. Results: Regression analyses were performed in 250 patients and revealed an association of variance of intraprocedural SBP (aOR, 1.002 (95% CI, 1.0004–1.004); p = 0.016) and average real variability of SBP (aOR, 1.105 (95% CI, 1.019–1.199); p = 0.016) with favorable outcome (modified Rankin Scale 0–2). Conclusion: In our study, intraprocedural BPV parameters during endovascular stroke treatment were positively associated with favorable clinical outcomes. Potential underlying mechanisms should be further explored to better understand the effects of hemodynamics during the hyperacute time frame of endovascular stroke therapy. Trial registration: Clinicaltrials.gov; NCT04578288.
- 11 November 2024
- Published by Taylor & Francis in Statistics in Biopharmaceutical Research
- Vol. 17 (3) , 446-456
A Basket Trial Design Based on Power Priors
- 11 November 2024
- Published by Taylor & Francis in Statistics in Biopharmaceutical Research
- Vol. 17 (3) , 446-456
A Basket Trial Design Based on Power Priors
- Open Access
- 9 November 2024
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 409 (1) , 1-9
Ghost-ileostomy versus conventional loop ileostomy in patients undergoing low anterior resection for rectal cancer: results of a randomised controlled multicentre pilot trial (DRKS00013997)
- 9 November 2024
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 409 (1) , 1-9
Open AccessGhost-ileostomy versus conventional loop ileostomy in patients undergoing low anterior resection for rectal cancer: results of a randomised controlled multicentre pilot trial (DRKS00013997)
- 26 September 2024
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 36 (2) , 245-277
Assessing the hierarchical beta-binomial model as a basic information sharing tool in basket trials
- 26 September 2024
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 36 (2) , 245-277
Assessing the hierarchical beta-binomial model as a basic information sharing tool in basket trials